š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The objective of this study was to investigate the single-dose relative bio...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2002-12
Trial ID
NCT00650481
Treatments Being Tested
For many years, antimuscarinics have been first-line pharmacological treatm...
Status
Completed
Location
Samsung Medical Center
Start Date
2009-02
Trial ID
NCT00836381
Treatments Being Tested
The objective of this study was to investigate the single-dose relative bio...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-07
Trial ID
NCT00649727
Treatments Being Tested
This study will investigate the safety and efficacy of Sanctura XR (trospiu...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01089751
Treatments Being Tested
To evaluate efficacy of tolterodine extended release formulation compared w...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-05
Trial ID
NCT00139724
Treatments Being Tested
Patients with overactive bladder are often treated with tolterodine, a medi...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2011-05
Trial ID
NCT01302054
Treatments Being Tested
This study will evaluate the safety and effectiveness of an anticholinergic...
Status
Completed
Location
Watson Investigational Site
Start Date
2004-12
Trial ID
NCT00224016
Treatments Being Tested
This is a Phase IV, prospective, randomized, multi-center study to find ris...
Status
Completed
Location
Samsung Medical Center
Start Date
2006-08
Trial ID
NCT00730535
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of toltero...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-03
Trial ID
NCT00645281
Treatments Being Tested
A Single-Dose Pharmacokinetics And Relative Bioavailability Study Of Tolter...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-10
Trial ID
NCT01521767